1. Home
  2. UAN vs SLN Comparison

UAN vs SLN Comparison

Compare UAN & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVR Partners LP

UAN

CVR Partners LP

N/A

Current Price

$126.17

Market Cap

1.3B

Sector

Industrials

ML Signal

N/A

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$19.66

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UAN
SLN
Founded
2007
1994
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2008
2010

Fundamental Metrics

Financial Performance
Metric
UAN
SLN
Price
$126.17
$19.66
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
★ $33.00
AVG Volume (30 Days)
14.7K
★ 3.9M
Earning Date
11-03-2026
11-05-2026
Dividend Yield
★ 8.42%
N/A
EPS Growth
★ 61.98
N/A
EPS
★ 12.06
N/A
Revenue
★ $606,038,000.00
$559,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$130.93
P/E Ratio
$10.45
★ N/A
Revenue Growth
★ 15.36
N/A
52 Week Low
$91.44
$4.19
52 Week High
$139.50
$19.69

Technical Indicators

Market Signals
Indicator
UAN
SLN
Relative Strength Index (RSI) 48.22 79.34
Support Level $121.91 $4.97
Resistance Level $130.40 N/A
Average True Range (ATR) 3.04 0.45
MACD 0.02 1.28
Stochastic Oscillator 25.67 99.86

Price Performance

Historical Comparison
UAN
SLN

About UAN CVR Partners LP

CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: